Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia
Top Cited Papers
Open Access
- 1 February 2002
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 1 (1) , 63-74
- https://doi.org/10.1016/s1535-6108(02)00016-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of DifferentiationMolecular and Cellular Biology, 2001
- Alterations of the AML1 transcription factor in human leukemiaSeminars in Cell & Developmental Biology, 2000
- Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP‐mediated recombination in the mouseEMBO Reports, 2000
- C-kit mutations in core binding factor leukemiasBlood, 2000
- Leukemogenesis by CBF oncoproteinsLeukemia, 1999
- The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemiaNature Genetics, 1999
- THE AML1‐ETO CHIMAERIC TRANSCRIPTION FACTOR IN ACUTE MYELOID LEUKAEMIA: BIOLOGY AND CLINICAL SIGNIFICANCEBritish Journal of Haematology, 1999
- Associations between morphology, karyotype, and clinical features in myeloid leukemiasHuman Pathology, 1987
- Myeloblastoma with an 8;21 chromosome translocation in acute myeloblastic leukemiaCancer, 1986
- Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemiaBlood, 1982